Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2001; 38:1866-1871
© 2001 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Billinger, M.
Right arrow Articles by Hess, O. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Billinger, M.
Right arrow Articles by Hess, O. M.

Do beta-adrenergic blocking agents increase coronary flow reserve?

Michael Billinger, MDa, Christian Seiler, MD, FACCa, Martin Fleisch, MDa, Franz R. Eberli, MDa, Bernhard Meier, MD, FACCa and Otto M. Hess, MD*,a

a Department of Cardiology, Swiss Cardiovascular Center, Bern, Switzerland



View larger version (110K):

[in a new window]
 
Figure 1 Representative recordings of coronary flow velocity signal in a patient with single-vessel disease undergoing percutaneous transluminal coronary angioplasty. The tracings are shown in the panels from top to bottom: electrocardiogram, aortic pressure, instantaneous flow velocity and flow velocity trend. Pharmacologic coronary flow velocity reserve (CFVR) (left): flow velocity at rest = 9.1 cm/s, maximal flow velocity after administration of 18 µg adenosine = 28 cm/s; CFVR: 28/9.1 = 3.1. Determination of postischemic CFVR (right): flow velocity after 1-min balloon occlusion = 28 cm/s; CFVR: 28/9.1 = 3.1. Pharmacologic CFVR after metoprolol (lower panels): flow velocity at rest = 9.7 cm/s, maximal flow velocity after adenosine = 36 cm/s; CFVR: 36/9.7 = 3.7. Postischemic CFVR: postischemic flow velocity = 41 cm/s; CFVR: 41/9.7 = 4.2.

 


View larger version (25K):

[in a new window]
 
Figure 2 Rate-pressure product: before (left) and after (right) 5 mg metoprolol, intravenous, at rest as well as during hyperemia. There is a significant reduction in the rate-pressure product after beta-blockade. ADO = adenosine.

 


View larger version (29K):

[in a new window]
 
Figure 3 Pharmacologic and postischemic coronary flow velocity reserve (CFVR) increased significantly from 2.1 ± 0.6 to 2.6 ± 0.9, respectively, from 2.7 ± 0.8 to 3.3 ± 1.0 after intravenous administration of 5 mg metoprolol. In two patients, there was no change in pharmacologic CFVR, but in another two patients there was even a decrease in CFVR after beta-blockade. Postischemic CFVR was generally higher than pharmacologic CFVR.

 


View larger version (37K):

[in a new window]
 
Figure 4 Coronary vascular resistance was slightly lower (NS) after metoprolol but significantly lower during pharmacologic, respectively, postischemic vasodilation. ADO = adenosine.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement